Ignite Creation Date:
2024-05-06 @ 12:57 AM
Last Modification Date:
2024-10-26 @ 10:57 AM
Study NCT ID:
NCT01697163
Status:
UNKNOWN
Last Update Posted:
2012-10-02
First Post:
2012-09-12
Brief Title:
De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
Sponsor:
Severance Hospital
Organization:
Severance Hospital
Organization Data
Organization:
Severance Hospital
Class:
OTHER
Study ID:
ISSIRES0067
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Severance Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Joo Hang Kim
Responsible Party Title:
Severance Hospital
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Severance Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |